Atria Investments Inc Has $9.32 Million Stake in McKesson Corporation $MCK

Atria Investments Inc lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 11.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,061 shares of the company’s stock after selling 1,555 shares during the quarter. Atria Investments Inc’s holdings in McKesson were worth $9,318,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in MCK. Solstein Capital LLC lifted its position in shares of McKesson by 171.4% during the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock valued at $28,000 after acquiring an additional 24 shares during the period. State of Wyoming acquired a new position in McKesson in the second quarter valued at about $29,000. Hopwood Financial Services Inc. bought a new stake in McKesson during the third quarter worth about $31,000. Abound Wealth Management grew its stake in McKesson by 104.3% during the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after buying an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC bought a new position in McKesson in the 2nd quarter valued at about $35,000. Institutional investors own 85.07% of the company’s stock.

Wall Street Analyst Weigh In

MCK has been the subject of several analyst reports. Evercore restated an “outperform” rating and issued a $1,000.00 target price on shares of McKesson in a research report on Thursday, November 6th. Morgan Stanley restated an “overweight” rating and set a $966.00 price objective on shares of McKesson in a research report on Thursday, January 29th. Zacks Research downgraded McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. Barclays assumed coverage on McKesson in a research note on Monday, December 8th. They issued an “overweight” rating and a $960.00 price target on the stock. Finally, TD Cowen upped their price objective on McKesson from $1,000.00 to $1,012.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $937.07.

Insider Buying and Selling

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.08% of the stock is owned by company insiders.

McKesson Stock Performance

Shares of NYSE:MCK opened at $916.08 on Friday. McKesson Corporation has a 52-week low of $585.22 and a 52-week high of $971.93. The company has a market capitalization of $112.21 billion, a PE ratio of 26.35, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. The company has a fifty day moving average of $837.61 and a 200-day moving average of $785.95.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same quarter in the previous year, the company posted $8.03 EPS. McKesson’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is currently 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.